APTAH Trademark
APTAH is a USPTO trademark filed by Aptah Bio Inc.. Status: Pending.
Trademark Facts
| Mark | APTAH |
|---|---|
| Serial Number | 97041301 |
| Status | Pending |
| Filing Date | 2021-09-23 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Aptah Bio Inc. |
| Attorney of Record | Alyssa M. Worsham |
| Prosecution Events | 44 |
| Latest Event | SUPC on 2026-04-15 |
Goods & Services
Pharmaceutical preparations for the configuration, modulation and correction of RNA transcript splicing, capping and tailing for the treatment of genetic diseases; pharmaceutical preparations for the configuration, modulation and correction of RNA for the treatment of genetic diseases; pharmaceutical preparations for restoring and reprograming RNA-protein interactions for the treatment of genetic diseases; pharmaceutical preparations for the treatment of genetic diseases associated with gene dysregulation, inhibition or suppression of gene expression; pharmaceutical preparations for the treatment of genetic diseases; gene therapy products, namely, molecules in the nature of genetically engineered tissues for controlling gene expression; medical molecular diagnostic tests for testing bodily fluid for the detection of genetic diseases; medical diagnostic tests for the detection of neurodegenerative, oncological and infectious diseases; Biomolecules in the nature of gene therapy products, namely, genetically engineered stem cells in the nature of synthetic cDNAs for controlling gene expression for medical and scientific research; Research and development of pharmaceuticals, namely, therapies for the configuration, modulation and correction of RNA transcript splicing, capping and tailing; scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, DNA, RNA, molecules and proteins; pharmaceutical products design and development in the field of biomolecules for medical and scientific use, and medical treatment; pharmaceutical drug design and development featuring biomolecules